Aralez Pharmaceuticals YOSPRALA 2016 FDA Approval Conference

Conference call presentation covering YOSPRALA product overview, U.S. market opportunity, and commercialization strategy following FDA approval in September 2016. Details include clinical data, sales force structure, pricing strategy at $150 per 30-count bottle, and relaunch plans for ZONTIVITY with patent protection through 2027.